Literature DB >> 26416675

Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke.

Irving Weissman1.   

Abstract

The appearance of stem cells coincides with the transition from single-celled organisms to metazoans. Stem cells are capable of self-renewal as well as differentiation. Each tissue is maintained by self-renewing tissue-specific stem cells. The accumulation of mutations that lead to preleukaemia are in the blood-forming stem cell, while the transition to leukaemia stem cells occurs in the clone at a progenitor stage. All leukaemia and cancer cells escape being removed by scavenger macrophages by expressing the 'don't eat me' signal CD47. Blocking antibodies to CD47 are therapeutics for all cancers, and are currently being tested in clinical trials in the US and UK.
© 2015 The Author(s).

Entities:  

Keywords:  cancer; competition; leukaemia; neoplasm; stem cell

Mesh：

Substances：

Year:  2015        PMID： 26416675      PMCID： PMC4633993          DOI： 10.1098/rstb.2014.0364

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN： 0962-8436            Impact factor:   6.237


  105 in total

1.  Physiological migration of hematopoietic stem and progenitor cells.

Authors:  D E Wright; A J Wagers; A P Gulati; F L Johnson; I L Weissman
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

2.  The identification, origin, and migration of the primordial germ cells in the mouse embryo.

Authors:  A D CHIQUOINE
Journal:  Anat Rec       Date:  1954-02

Review 3.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

4.  Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment.

Authors:  S Brocke; C Piercy; L Steinman; I L Weissman; T Veromaa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

5.  Separation and labeling of specific subpopulations of Botryllus blood cells.

Authors:  J M Schlumpberger; I L Weissman; V L Scofield
Journal:  J Exp Zool       Date:  1984-03

Review 6.  Programmed cell removal: a new obstacle in the road to developing cancer.

Authors:  Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Nat Rev Cancer       Date:  2011-12-08       Impact factor: 60.716

7.  Telomerase maintained in self-renewing tissues during serial regeneration of the urochordate Botryllus schlosseri.

Authors:  Diana J Laird; Irving L Weissman
Journal:  Dev Biol       Date:  2004-09-15       Impact factor: 3.582

Review 8.  A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells.

Authors:  Samuel H Cheshier; M Yashar S Kalani; Michael Lim; Laurie Ailles; Steven L Huhn; Irving L Weissman
Journal:  Neurosurgery       Date:  2009-08       Impact factor: 4.654

9.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

10.  Major age-related changes of mouse hematopoietic stem/progenitor cells.

Authors:  Mijung Kim; Hee-Bom Moon; Gerald J Spangrude
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691
View more
  5 in total

Review 1.  Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.

Authors:  Sukhbir Kaur; David D Roberts
Journal:  Int J Biochem Cell Biol       Date:  2016-05-06       Impact factor: 5.085

2.  OMIP-059: Identification of Mouse Hematopoietic Stem and Progenitor Cells with Simultaneous Detection of CD45.1/2 and Controllable Green Fluorescent Protein Expression by a Single Staining Panel.

Authors:  Marcus Eich; Andreas Trumpp; Steffen Schmitt
Journal:  Cytometry A       Date:  2019-07-07       Impact factor: 4.355

3.  Two distinct evolutionary conserved neural degeneration pathways characterized in a colonial chordate.

Authors:  Chiara Anselmi; Mark Kowarsky; Fabio Gasparini; Federico Caicci; Katherine J Ishizuka; Karla J Palmeri; Tal Raveh; Rahul Sinha; Norma Neff; Stephen R Quake; Irving L Weissman; Ayelet Voskoboynik; Lucia Manni
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-11       Impact factor: 12.779

Review 4.  Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer.

Authors:  Mario Orozco-Morales; Giovanny Soca-Chafre; Pedro Barrios-Bernal; Norma Hernández-Pedro; Oscar Arrieta
Journal:  Mediators Inflamm       Date:  2016-01-28       Impact factor: 4.711

5.  Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy.

Authors:  Clemens Woywod; Franz X Gruber; Richard A Engh; Tor Flå
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.